The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches

This publication has 31 references indexed in Scilit:

• Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
  The Lancet Oncology, 2014
• Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
  Journal of Clinical Oncology, 2014
• Keeping it simple: Genetics referrals for all invasive serous ovarian cancers
  Gynecologic Oncology, 2013
• Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing
  Gynecologic Oncology, 2013
• Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer
  Obstetrics & Gynecology, 2012
• BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
  Journal of Clinical Oncology, 2012
• Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
  Proceedings of the National Academy of Sciences, 2011
• Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
  JAMA, 2010
• Leiden open variation database of the MUTYH gene
  Human Mutation, 2010
• Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian Cancer
  JAMA, 2005